Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia-Reference-Cited by-同舟云学术

Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia

Published:2013-09-09 Issue:11 Volume:88 Page:961-966
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Nazha Aziz¹,Kantarjian Hagop¹,Ravandi Farhad¹,Huang Xuelin¹,Choi Sangbum¹,Garcia-Manero Guillermo¹,Jabbour Elias¹,Borthakur Gautam¹,Kadia Tapan¹,Konopleva Marina¹,Cortes Jorge¹,Ferrajoli Alessandra¹,Kornblau Steve¹,Daver Naval¹,Pemmaraju Naveen¹,Andreeff Michael¹,Estrov Zeev¹,Du Min¹,Brandt Mark¹,Faderl Stefan¹

Affiliation:

1. Department of Leukemia; The University of Texas-M.D. Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23544/fullpdf

Reference28 articles.

1. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia;Yates;Cancer Chemother Rep,1973

2. Treatment of acute myelocytic leukemia: A study by cancer and leukemia group B;Rai;Blood,1981

3. Acute myeloid leukemia;O'Donnell;J Natl Compr Canc Netw,2011